Phase 1 DLBCL (Diffuse Large B-Cell Lymphoma) Associated With Chronic Inflammation Clinical Trials
1 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.